Gemcitabine in Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer
Abstract
Am J Cancer 2005; 4 (5): 334-335 GUEST COMMENTARIES 1175-6357/05/0005-0334/$34.95/0 © 2005 Adis Data Information BV. All rights reserved. much controversy exists regarding the administration of combina- Gemcitabine in Combination with Paclitaxel tion chemotherapy versus single agents in metastatic breast cancer, in the First-Line Treatment of Metastatic one can not refute the results of the prospective phase III trial, Breast Cancer which endorse the gemcitabine plus paclitaxel...